Can statins alter coronary plaque composition assessed by radiofrequency backscatter intravascular ultrasound?
Samady
Habib
H
McDaniel
Michael C
MC
D002114:Calcinosis / Q000000981:diagnostic imaging / Q000188:drug therapy; D003324:Coronary Artery Disease / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D005229:Fatty Acids, Monounsaturated / Q000627:therapeutic use; D005355:Fibrosis; D005464:Fluorobenzenes / Q000627:therapeutic use; D000077340:Fluvastatin; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D007211:Indoles / Q000627:therapeutic use; D009336:Necrosis; D015588:Observer Variation; D011237:Predictive Value of Tests; D011743:Pyrimidines / Q000627:therapeutic use; D011859:Radiography; D000068718:Rosuvastatin Calcium; D012720:Severity of Illness Index; D019821:Simvastatin / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome; D018084:Ultrasonography, Interventional; D014584:User-Computer Interface
D005229:Fatty Acids, Monounsaturated; D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007211:Indoles; D011743:Pyrimidines; D013449:Sulfonamides; D000077340:Fluvastatin; D000068718:Rosuvastatin Calcium; D019821:Simvastatin